Internal Medicine · Winchester, TN
NPI
1174501027
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1509 Old Cowan Rd
Winchester, TN, 37398
Phone (931) 962-2540
Groups this clinician bills Medicare through
Medicare paid, 2024
$527K
9,574 services
Medicare patients, 2024
466
Average age 77
Drug cost, 2024
$2.7M
24,980 prescriptions
Company payments, 2025
$1,893
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ephraim B Gammada was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,880 times for 35 patients. In total Ephraim B Gammada billed 9,574 services in 127 codes, and Medicare paid $527K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,880 | 35 | $0.10 | $188 |
| 99214 Office E&M - Established | Office | 1,183 | 348 | $77.39 | $92K |
| G6001 Ultrasonic guidance for placement of radiation therapy fields | Office | 604 | 25 | $127.19 | $77K |
| 77280 Radiation Treatment Planning | Office | 571 | 25 | $188.79 | $108K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 562 | 47 | $0.08 | $45.63 |
| 77401 Conventional Radiation Treatment | Office | 553 | 25 | $29.05 | $16K |
| 99213 Office E&M - Established | Office | 485 | 177 | $61.44 | $30K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 244 | 32 | $0.31 | $75.5 |
| 96372 Injection Administration | Office | 234 | 84 | $9.04 | $2,115 |
| 99232 Hospital E&M - Subsequent | Facility | 201 | 49 | $57.65 | $12K |
| 99497 Care Management/Coordination | Office | 191 | 189 | $71.87 | $14K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 174 | 174 | $118.46 | $21K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 172 | 172 | $17.03 | $2,930 |
| 81003 Clinical Chemistry | Office | 164 | 99 | $2.20 | $361 |
| 99308 SNF E&M | Facility | 150 | 43 | $51.49 | $7,723 |
By year: 2022 $545K for 10,822 services; 2023 $556K for 8,477 services; 2024 $527K for 9,574 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 164 | 99 | $2.20 | $361 |
Medicare prescription drug claims, 2024
In 2024, the drug Ephraim B Gammada prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,153 prescriptions and refills. In total Ephraim B Gammada wrote 24,980 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,153 | 2,358 | 213 | $9,074 |
| Potassium Chloride Generic | 804 | 1,145 | 115 | $16K |
| Rosuvastatin Calcium Generic | 733 | 1,928 | 212 | $13K |
| Furosemide Generic | 688 | 983 | 116 | $4,331 |
| Omeprazole Generic | 688 | 1,791 | 200 | $11K |
| Gabapentin Generic | 549 | 616 | 87 | $6,483 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 521 | 521 | 95 | $8,157 |
| Eliquis Apixaban | 457 | 545 | 46 | $187K |
| Losartan Potassium Generic | 453 | 1,160 | 139 | $6,283 |
| Xarelto Rivaroxaban | 434 | 521 | 56 | $172K |
| Pantoprazole Sodium Generic | 425 | 768 | 79 | $5,712 |
| Atorvastatin Calcium Generic | 415 | 863 | 113 | $6,143 |
| Amlodipine Besylate Generic | 403 | 880 | 104 | $3,053 |
| Alprazolam Generic | 382 | 382 | 63 | $1,851 |
| Metoprolol Tartrate Generic | 366 | 653 | 68 | $2,806 |
Brand drugs: 4,729 claims; generic drugs: 20,182 claims; opioid claims: 974.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ephraim B Gammada $1,893 ($1,893 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $418.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 11 | $418 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $262 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $182 |
| Merck Sharp & Dohme LLC MRK | 7 | $176 |
| Lilly USA, LLC LLY | 10 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $130 |
| Amgen Inc. AMGN | 6 | $106 |
| Xeris Pharmaceuticals, Inc. | 4 | $101 |
| Axsome Therapeutics, Inc. AXSM | 4 | $101 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $79.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.